Header Logo

Connection

JOHN VIERLING to RNA, Small Interfering

Back to Details
This is a "connection" page, showing publications JOHN VIERLING has written about RNA, Small Interfering.
JOHN VIERLING
Connection Strength
0.047
RNA, Small Interfering
  1. Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA). Gastroenterology. 2024 Oct; 167(5):1008-1018.e5.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.